NGN 103
Alternative Names: NGN-103Latest Information Update: 26 Oct 2022
At a glance
- Originator Neurogene Inc
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Neuronal ceroid lipofuscinosis